Connection
Jeffrey Bennett to Complement Inactivating Agents
This is a "connection" page, showing publications Jeffrey Bennett has written about Complement Inactivating Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.935 |
|
|
|
-
Given KS, Acker EG, Macklin WB, Carlin D, Owens GP, Bennett JL. Complement inhibition rapidly blocks lesion extension and facilitates remyelination in neuromyelitis optica. Acta Neuropathol Commun. 2025 06 12; 13(1):129.
Score: 0.887
-
Pittock SJ, Barnett M, Bennett JL, Berthele A, de Sèze J, Levy M, Nakashima I, Oreja-Guevara C, Palace J, Paul F, Pozzilli C, Yountz M, Allen K, Mashhoon Y, Kim HJ. Ravulizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder. Ann Neurol. 2023 06; 93(6):1053-1068.
Score: 0.048